EGFR and small cell lung carcinoma: For example, models “Bidkhori2012 - normal EGFR signaling” (BIOMD0000000452) and “Bidkhori2012 - EGFR signaling in NSCLC” (BIOMD0000000453), describe the cross-talk mechanism between Ras/ERK, PI3K/AKT, and JAK/STAT pathways in normal and non–small-cell lung cancer (NSCLC) cells,26 respectively, and are both derived from several other models.